Suri Anish 4
4 · Cue Biopharma, Inc. · Filed Feb 21, 2023
Insider Transaction Report
Form 4
Suri Anish
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-16+125,500→ 125,500 totalExercise: $3.21Exp: 2033-02-15→ Common Stock (125,500 underlying)
Footnotes (1)
- [F1]This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023.